SCHEMBL6884409

SCHEMBL6884409

C=Cc1ccc(C=Cc2ccc(C=Cc3ccc(C(C)(C)C)cc3)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.53
ALDH1A1 P00352 4/20 0.50
TSHR P16473 2/20 0.42
NR1H2 P55055 1/20 0.41
NR1H3 Q13133 1/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
MAPT P10636 2/20 0.41
TRPV1 Q8NER1 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
LMNA P02545 4/20 0.41
TYR P14679 1/20 0.41
GRIN2D O15399 2/20 0.40
GRIN3B O60391 2/20 0.40
GRIN1 Q05586 2/20 0.40
GRIN2A Q12879 2/20 0.40
GRIN2B Q13224 2/20 0.40
GRIN2C Q14957 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6876844 1.00 CYP1A2 (0.53) CYP1A2ALDH1A1TSHRNR1H2NR1H3
SCHEMBL15198 0.93 ALDH1A1 (0.58) CYP1A2ALDH1A1TSHRNPC1RAB9A
Ammonia Solution, Strong SCHEMBL28148721 0.91 ALDH1A1 (0.55) CYP1A2ALDH1A1TSHRNPC1RAB9A
Hydrogen Sulfide SCHEMBL29029008 0.91 ALDH1A1 (0.55) CYP1A2ALDH1A1TSHRSMN1; SMN2TRPV1
Ethylene SCHEMBL28319400 0.91 ALDH1A1 (0.55) CYP1A2ALDH1A1TSHRNPC1RAB9A
Methane SCHEMBL27697370 0.91 ALDH1A1 (0.55) CYP1A2ALDH1A1TSHRSMN1; SMN2TRPV1
Butadiene SCHEMBL4270330 0.88 ALDH1A1 (0.52) CYP1A2ALDH1A1TSHRSMN1; SMN2MAPT
SCHEMBL1825729 0.88 CYP1A2 (0.64) CYP1A2ALDH1A1TSHRNR1H2NR1H3
SCHEMBL1825727 0.88 CYP1A2 (0.64) CYP1A2ALDH1A1TSHRNR1H2NR1H3
Methoxymethane SCHEMBL28668345 0.86 ALDH1A1 (0.50) CYP1A2ALDH1A1TSHRNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030055278-A1 Soluble tetrahedral compounds for use in electroluminescent devices NATIONAL SCIENCE FOUNDATION 2003-03-20 US claimed
WO-2001083410-A1 SOLUBLE TETRAHEDRAL COMPOUNDS FOR USE IN ELECTROLUMINESCENT DEVICES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2001-11-08 WO claimed
US-6824890-B2 TOPOLOGICAL STRATEGY FOR DESIGNING AMORPHOUS MOLECULAR SOLIDS FOR FORMING THIN FILMS IN OPTOELECTRONIC DEVICES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2004-11-30 US disclosed
US-20030055278-A1 Soluble tetrahedral compounds for use in electroluminescent devices NATIONAL SCIENCE FOUNDATION 2003-03-20 US disclosed
WO-2001083410-A1 SOLUBLE TETRAHEDRAL COMPOUNDS FOR USE IN ELECTROLUMINESCENT DEVICES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2001-11-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030055278-A1 Soluble tetrahedral compounds for use in electroluminescent devices PAX3, EPCAM, PAXBP1 CYP1A2 4640/4885ALDH1A1 3724/4885TSHR 2644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.